DUBLIN--(BUSINESS WIRE)--The "Primary Hyperoxaluria - Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.
The Primary Hyperoxaluria epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Primary Hyperoxaluria epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM.
The Primary Hyperoxaluria epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Scope of the Report
- The Primary Hyperoxaluria report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
- The Primary Hyperoxaluria Epidemiology Report and Model provide an overview of the global trends of Primary Hyperoxaluria in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
- The report provides insight into the historical and forecasted patient pool of Primary Hyperoxaluria in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
- The report helps recognize the growth opportunities in the 7MM for the patient population
- The report assesses the disease risk and burden and highlights the unmet needs of Primary Hyperoxaluria
- The report provides the segmentation of the Primary Hyperoxaluria epidemiology
Report Highlights
- 11-year Forecast of Primary Hyperoxaluria epidemiology
- 7MM Coverage
- Prevalent and Diagnosed Cases of Primary Hyperoxaluria
- Cases of Primary Hyperoxaluria by Mutation Types
- Primary Hyperoxaluria Cases associated with Clinical Manifestations
Key Assessments
- Patient Segmentation
- Disease Risk & Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Key Topics Covered:
1. Key Insights
2. Executive Summary of Primary Hyperoxaluria
3. Primary Hyperoxaluria: Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Primary Hyperoxaluria Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
5.4.1. Primary Hyperoxaluria Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Primary Hyperoxaluria Epidemiology Scenario in Germany (2019- 2032)
5.5.2. France Epidemiology
5.5.2.1. Primary Hyperoxaluria Epidemiology Scenario in France (2019- 2032)
5.5.3. Italy Epidemiology
5.5.3.1. Primary Hyperoxaluria Epidemiology Scenario in Italy (2019- 2032)
5.5.4. Spain Epidemiology
5.5.4.1. Primary Hyperoxaluria Epidemiology Scenario in Spain (2019- 2032)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Primary Hyperoxaluria Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
5.6.1. Primary Hyperoxaluria Epidemiology Scenario in Japan (2019- 2032)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Primary Hyperoxaluria Treatment and Management
6.2. Primary Hyperoxaluria Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/796ws3
